Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Current '336 request, corrections welcome - More confusion

< Per my understanding, with the issuance of the cert on the amended '336 per the recently completed prior re-exam, the amended '336 is available for public view. >

I believe public view would only be when published. My point however is that if terminated, and a reexam cert issued, (which the patent owner can use as a defense against any new SNQ) why would the USPTO want to keep is a secret from the public at large? With the issuance of the reexam certificate, the patent owner knows, the USPTO knows and the 3rd party requester knows. Makes no sense at all to keep it from everyone else. And I believe we are both of the opinion that publishing is simply a formality.

GLTA, Opty

Share
New Message
Please login to post a reply